-+ 0.00%
-+ 0.00%
-+ 0.00%

Freedom Broker Maintains Buy on INmune Bio, Lowers Price Target to $2.5

Benzinga·11/13/2026 19:27:42
Listen to the news
Freedom Broker analyst Ilya Zubkov maintains INmune Bio (NASDAQ:INMB) with a Buy and lowers the price target from $4 to $2.5.